Strategy Driven by Innovation

Over 40 years of excellence in Research and Development

 We devote $75.4 million to R&D, accounting for over 10.3% of sales.

15% of our employees (over 500 people) work in R&D in centers in North America, France, Italy and Germany.

Our multidisciplinary teams bring together researchers from different backgrounds to offer a broad range of technical and scientific expertise.

Our “Engineer-Physician Intelligence Networks” provide a continuous source of knowledge and ideas in order to develop innovative therapeutic solutions for patients and healthcare professionals.

We have forged partnerships with cardiology specialists at world renowned universities and research centers across the globe.

Our portfolio contains over 2,000 patents.

 

Technology at the cutting edge

SORIN GROUP develops “smart” medical devices to save lives and improve patient comfort. Some of our recent developments include:

 

INSPIRE OXYGENATORS* SONR CRT OPTIMIZATION SYSTEM* SUTURELESS MINIMALLY INVASIVE HEART VALVE

INSPIRE™ is a new family of oxygenators for extracorporeal circulation in adult patients that is designed to offer clinicians a personalized and truly optimized approach to perfusion.
The two product sub-families, INSPIRE™ 6 and INSPIRE™ 8, offer clinicians the most suitable solution according to their patient’s weight. These products provide powerful and consistent performance combined with low impact on hemodilution and optimal reduction of gaseous micro emboli (GME), which are a potential source of neurological damage for cardiac surgery patients.
 

SonR™ is the only weekly self-adjusting CRT optimization system that provides optimized timing at rest and exercise for improved CRT response. This system is composed of the PARADYM* RF SonR device and the SonRtip lead embedded with the SonR sensor.
Paradym ™ RF SonR is remote monitoring enabled with SORIN’s SMARTVIEW™* system. The SMARTVIEW easy-to-use remote monitoring solution transmits data recorded by the implanted SonR device from the patient’s home to the physician, offering peace of mind for physicians and patients alike.
*Not available for sale or distribution in the U.S.

PERCEVAL™ S is a new-generation sutureless aortic heart valve.
The valve is collapsed right before implant in order to enhance visualization and make positioning easier even when dealing with narrow spaces. PERCEVAL™ S does not need any suture, making it the best option in minimally invasive surgical (MIS) approaches.
*Not available for sale or
distribution in the U.S.

SORIN GROUP is committed to continuous innovation through interdisciplinary structures of research and development. This is achieved by integrating science and technology into products and processes: from biology to medicine, materials science to electronics, micro-electronics and information technology.

Up